MERY Fundamental Analysis - MERCIALYS

Fundamental Rating

MERY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. While MERY is still in line with the averages on profitability rating, there are concerns on its financial health. MERY is valued correctly, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

MERY had positive earnings in the past year.

MERY had a positive operating cash flow in the past year.

In the past 5 years MERY has always been profitable.

Each year in the past 5 years MERY had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 1.28%, MERY is in line with its industry, outperforming 42.86% of the companies in the same industry.

The Return On Equity of MERY (5.46%) is comparable to the rest of the industry.

With a Return On Invested Capital value of 2.81%, MERY is not doing good in the industry: 61.90% of the companies in the same industry are doing better.

Measured over the past 3 years, the Average Return On Invested Capital for MERY is in line with the industry average of 3.38%.

		Industry Rank	Sector Rank
ROA	1.28%
ROE	5.46%
ROIC	2.81%

ROA(3y)2.28%

ROA(5y)2.51%

ROE(3y)7.45%

ROE(5y)8.62%

ROIC(3y)4.41%

ROIC(5y)4.49%

1.3 Margins

The Profit Margin of MERY (17.79%) is comparable to the rest of the industry.

MERY's Profit Margin has declined in the last couple of years.

The Operating Margin of MERY (43.31%) is worse than 73.81% of its industry peers.

In the last couple of years the Operating Margin of MERY has declined.

MERY has a Gross Margin of 95.26%. This is amongst the best in the industry. MERY outperforms 90.48% of its industry peers.

In the last couple of years the Gross Margin of MERY has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	43.31%
PM (TTM)	17.79%
GM	95.26%

OM growth 3Y-0.44%

OM growth 5Y-1.55%

PM growth 3Y-6.05%

PM growth 5Y-8.66%

GM growth 3Y1.08%

GM growth 5Y0.54%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MERY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

Compared to 1 year ago, MERY has less shares outstanding

The number of shares outstanding for MERY has been increased compared to 5 years ago.

The debt/assets ratio for MERY is higher compared to a year ago.

2.2 Solvency

MERY has an Altman-Z score of 0.52. This is a bad value and indicates that MERY is not financially healthy and even has some risk of bankruptcy.

MERY has a worse Altman-Z score (0.52) than 73.81% of its industry peers.

MERY has a debt to FCF ratio of 11.36. This is a negative value and a sign of low solvency as MERY would need 11.36 years to pay back of all of its debts.

MERY's Debt to FCF ratio of 11.36 is in line compared to the rest of the industry. MERY outperforms 59.52% of its industry peers.

A Debt/Equity ratio of 2.29 is on the high side and indicates that MERY has dependencies on debt financing.

Looking at the Debt to Equity ratio, with a value of 2.29, MERY is doing worse than 90.48% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	2.29
Debt/FCF	11.36
Altman-Z	0.52

ROIC/WACC0.52

WACC5.44%

2.3 Liquidity

MERY has a Current Ratio of 1.11. This is a normal value and indicates that MERY is financially healthy and should not expect problems in meeting its short term obligations.

MERY's Current ratio of 1.11 is amongst the best of the industry. MERY outperforms 83.33% of its industry peers.

A Quick Ratio of 1.11 indicates that MERY should not have too much problems paying its short term obligations.

With an excellent Quick ratio value of 1.11, MERY belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.11
Quick Ratio	1.11

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

MERY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.87%.

MERY shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.10% yearly.

MERY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.45%.

Measured over the past years, MERY shows a decrease in Revenue. The Revenue has been decreasing by -1.32% on average per year.

EPS 1Y (TTM)-64.87%

EPS 3Y-4.95%

EPS 5Y-10.1%

EPS Q2Q%-61.58%

Revenue 1Y (TTM)-34.45%

Revenue growth 3Y1.39%

Revenue growth 5Y-1.32%

Sales Q2Q%-3.09%

3.2 Future

MERY is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.43% yearly.

MERY is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.40% yearly.

EPS Next Y7.79%

EPS Next 2Y5.18%

EPS Next 3Y3.43%

EPS Next 5YN/A

Revenue Next Year2.72%

Revenue Next 2Y3.96%

Revenue Next 3Y3.4%

Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 32.06, which means the current valuation is very expensive for MERY.

MERY's Price/Earnings ratio is a bit more expensive when compared to the industry. MERY is more expensive than 64.29% of the companies in the same industry.

When comparing the Price/Earnings ratio of MERY to the average of the S&P500 Index (27.07), we can say MERY is valued inline with the index average.

MERY is valuated reasonably with a Price/Forward Earnings ratio of 8.75.

85.71% of the companies in the same industry are more expensive than MERY, based on the Price/Forward Earnings ratio.

When comparing the Price/Forward Earnings ratio of MERY to the average of the S&P500 Index (22.59), we can say MERY is valued rather cheaply.

		Industry Rank	Sector Rank
PE	32.06
Fwd PE	8.75

4.2 Price Multiples

MERY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MERY is cheaper than 61.90% of the companies in the same industry.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MERY indicates a rather cheap valuation: MERY is cheaper than 90.48% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	6.75
EV/EBITDA	17.05

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

PEG (NY)4.12

PEG (5Y)N/A

EPS Next 2Y5.18%

EPS Next 3Y3.43%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

MERY has a Yearly Dividend Yield of 9.31%, which is a nice return.

Compared to an average industry Dividend Yield of 5.48, MERY pays a better dividend. On top of this MERY pays more dividend than 100.00% of the companies listed in the same industry.

MERY's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.

		Industry Rank	Sector Rank
Dividend Yield	9.31%

5.2 History

The dividend of MERY decreases each year by -1.82%.

Dividend Growth(5Y)-1.82%

Div Incr Years4

Div Non Decr Years4

5.3 Sustainability

MERY pays out 297.27% of its income as dividend. This is not a sustainable payout ratio.

DP297.27%

EPS Next 2Y5.18%

EPS Next 3Y3.43%

More info and screens

Find the best dividend stocks

Show peers with best dividend

MERCIALYS

EPA:MERY (9/9/2025, 5:29:31 PM)

10.9

-0.06 (-0.55%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)07-24 2025-07-24

Earnings (Next)02-10 2026-02-10/amc

Inst Owners44.2%

Inst Owner ChangeN/A

Ins Owners0.26%

Ins Owner ChangeN/A

Market Cap1.02B

Analysts75.71

Price Target12.94 (18.72%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	9.31%

Yearly Dividend0.99

Dividend Growth(5Y)-1.82%

DP297.27%

Div Incr Years4

Div Non Decr Years4

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0.89%

PT rev (3m)3.47%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-4.03%

EPS NY rev (3m)-4.03%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0.58%

Revenue NY rev (3m)1%

Valuation

		Industry Rank	Sector Rank
PE	32.06
Fwd PE	8.75
P/S	5.79
P/FCF	6.75
P/OCF	6.75
P/B	1.78
P/tB	1.85
EV/EBITDA	17.05

EPS(TTM)0.34

EY3.12%

EPS(NY)1.25

Fwd EY11.43%

FCF(TTM)1.61

FCFY14.81%

OCF(TTM)1.61

OCFY14.81%

SpS1.88

BVpS6.13

TBVpS5.88

PEG (NY)4.12

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	1.28%
ROE	5.46%
ROCE	3.83%
ROIC	2.81%
ROICexc	3.61%
ROICexgc	3.67%
OM	43.31%
PM (TTM)	17.79%
GM	95.26%
FCFM	85.79%

ROA(3y)2.28%

ROA(5y)2.51%

ROE(3y)7.45%

ROE(5y)8.62%

ROIC(3y)4.41%

ROIC(5y)4.49%

ROICexc(3y)4.94%

ROICexc(5y)5.16%

ROICexgc(3y)4.95%

ROICexgc(5y)5.17%

ROCE(3y)6%

ROCE(5y)6.11%

ROICexcg growth 3Y4.57%

ROICexcg growth 5Y0.29%

ROICexc growth 3Y4.59%

ROICexc growth 5Y0.28%

OM growth 3Y-0.44%

OM growth 5Y-1.55%

PM growth 3Y-6.05%

PM growth 5Y-8.66%

GM growth 3Y1.08%

GM growth 5Y0.54%

F-Score5

Asset Turnover0.07

Health

		Industry Rank	Sector Rank
Debt/Equity	2.29
Debt/FCF	11.36
Debt/EBITDA	9.75
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	1.3
Cash Conversion	111.91%
Profit Quality	482.16%
Current Ratio	1.11
Quick Ratio	1.11
Altman-Z	0.52

F-Score5

WACC5.44%

ROIC/WACC0.52

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)300.14%

Profit Quality(5y)255.17%

High Growth Momentum

Growth

EPS 1Y (TTM)-64.87%

EPS 3Y-4.95%

EPS 5Y-10.1%

EPS Q2Q%-61.58%

EPS Next Y7.79%

EPS Next 2Y5.18%

EPS Next 3Y3.43%

EPS Next 5YN/A

Revenue 1Y (TTM)-34.45%

Revenue growth 3Y1.39%

Revenue growth 5Y-1.32%

Sales Q2Q%-3.09%

Revenue Next Year2.72%

Revenue Next 2Y3.96%

Revenue Next 3Y3.4%

Revenue Next 5YN/A

EBIT growth 1Y-47.18%

EBIT growth 3Y0.95%

EBIT growth 5Y-2.84%

EBIT Next Year32.15%

EBIT Next 3Y11.4%

EBIT Next 5YN/A

FCF growth 1Y12.87%

FCF growth 3Y5.97%

FCF growth 5Y0.83%

OCF growth 1Y12.87%

OCF growth 3Y5.97%

OCF growth 5Y0.83%

MERCIALYS (MERY.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens